Cargando…

Crystal structures of the human neurokinin 1 receptor in complex with clinically used antagonists

Neurokinins (or tachykinins) are peptides that modulate a wide variety of human physiology through the neurokinin G protein-coupled receptor family, implicated in a diverse array of pathological processes. Here we report high-resolution crystal structures of the human NK(1) receptor (NK(1)R) bound t...

Descripción completa

Detalles Bibliográficos
Autores principales: Schöppe, Jendrik, Ehrenmann, Janosch, Klenk, Christoph, Rucktooa, Prakash, Schütz, Marco, Doré, Andrew S., Plückthun, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6318301/
https://www.ncbi.nlm.nih.gov/pubmed/30604743
http://dx.doi.org/10.1038/s41467-018-07939-8
_version_ 1783384848026566656
author Schöppe, Jendrik
Ehrenmann, Janosch
Klenk, Christoph
Rucktooa, Prakash
Schütz, Marco
Doré, Andrew S.
Plückthun, Andreas
author_facet Schöppe, Jendrik
Ehrenmann, Janosch
Klenk, Christoph
Rucktooa, Prakash
Schütz, Marco
Doré, Andrew S.
Plückthun, Andreas
author_sort Schöppe, Jendrik
collection PubMed
description Neurokinins (or tachykinins) are peptides that modulate a wide variety of human physiology through the neurokinin G protein-coupled receptor family, implicated in a diverse array of pathological processes. Here we report high-resolution crystal structures of the human NK(1) receptor (NK(1)R) bound to two small-molecule antagonist therapeutics – aprepitant and netupitant and the progenitor antagonist CP-99,994. The structures reveal the detailed interactions between clinically approved antagonists and NK(1)R, which induce a distinct receptor conformation resulting in an interhelical hydrogen-bond network that cross-links the extracellular ends of helices V and VI. Furthermore, the high-resolution details of NK(1)R bound to netupitant establish a structural rationale for the lack of basal activity in NK(1)R. Taken together, these co-structures provide a comprehensive structural basis of NK(1)R antagonism and will facilitate the design of new therapeutics targeting the neurokinin receptor family.
format Online
Article
Text
id pubmed-6318301
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-63183012019-01-07 Crystal structures of the human neurokinin 1 receptor in complex with clinically used antagonists Schöppe, Jendrik Ehrenmann, Janosch Klenk, Christoph Rucktooa, Prakash Schütz, Marco Doré, Andrew S. Plückthun, Andreas Nat Commun Article Neurokinins (or tachykinins) are peptides that modulate a wide variety of human physiology through the neurokinin G protein-coupled receptor family, implicated in a diverse array of pathological processes. Here we report high-resolution crystal structures of the human NK(1) receptor (NK(1)R) bound to two small-molecule antagonist therapeutics – aprepitant and netupitant and the progenitor antagonist CP-99,994. The structures reveal the detailed interactions between clinically approved antagonists and NK(1)R, which induce a distinct receptor conformation resulting in an interhelical hydrogen-bond network that cross-links the extracellular ends of helices V and VI. Furthermore, the high-resolution details of NK(1)R bound to netupitant establish a structural rationale for the lack of basal activity in NK(1)R. Taken together, these co-structures provide a comprehensive structural basis of NK(1)R antagonism and will facilitate the design of new therapeutics targeting the neurokinin receptor family. Nature Publishing Group UK 2019-01-03 /pmc/articles/PMC6318301/ /pubmed/30604743 http://dx.doi.org/10.1038/s41467-018-07939-8 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Schöppe, Jendrik
Ehrenmann, Janosch
Klenk, Christoph
Rucktooa, Prakash
Schütz, Marco
Doré, Andrew S.
Plückthun, Andreas
Crystal structures of the human neurokinin 1 receptor in complex with clinically used antagonists
title Crystal structures of the human neurokinin 1 receptor in complex with clinically used antagonists
title_full Crystal structures of the human neurokinin 1 receptor in complex with clinically used antagonists
title_fullStr Crystal structures of the human neurokinin 1 receptor in complex with clinically used antagonists
title_full_unstemmed Crystal structures of the human neurokinin 1 receptor in complex with clinically used antagonists
title_short Crystal structures of the human neurokinin 1 receptor in complex with clinically used antagonists
title_sort crystal structures of the human neurokinin 1 receptor in complex with clinically used antagonists
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6318301/
https://www.ncbi.nlm.nih.gov/pubmed/30604743
http://dx.doi.org/10.1038/s41467-018-07939-8
work_keys_str_mv AT schoppejendrik crystalstructuresofthehumanneurokinin1receptorincomplexwithclinicallyusedantagonists
AT ehrenmannjanosch crystalstructuresofthehumanneurokinin1receptorincomplexwithclinicallyusedantagonists
AT klenkchristoph crystalstructuresofthehumanneurokinin1receptorincomplexwithclinicallyusedantagonists
AT rucktooaprakash crystalstructuresofthehumanneurokinin1receptorincomplexwithclinicallyusedantagonists
AT schutzmarco crystalstructuresofthehumanneurokinin1receptorincomplexwithclinicallyusedantagonists
AT doreandrews crystalstructuresofthehumanneurokinin1receptorincomplexwithclinicallyusedantagonists
AT pluckthunandreas crystalstructuresofthehumanneurokinin1receptorincomplexwithclinicallyusedantagonists